NHC - National HealthCare Corporation
NYSE
->
Healthcare
->
Medical Care Facilities
Murfreesboro,
United States
Type: Equity
NHC price evolution
NHC
| (in millions $) | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $110.1 | $126.15 | $109.05 | $102.6 |
| Inventory | $6.63 | $6.76 | $7.39 | $7.37 |
| Total current assets | $447.87 | $417.59 | $406.24 | $382.58 |
| Long term investments | ||||
| Property, plant & equipment | $568.01 | $576.05 | $587.53 | $599.05 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1339.7 | $1319.64 | $1310.8 | $1281.91 |
| Current liabilities | ||||
| Accounts payable | $21.78 | $20.7 | $19.19 | $16.47 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $216.94 | $206.43 | $214.48 | $204.69 |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $393.88 | $394.89 | $402.04 | $396.74 |
| Shareholders' equity | ||||
| Retained earnings | $722.16 | $704.73 | $687.6 | $668.24 |
| Other shareholder equity | -$5.91 | -$7.04 | -$6.6 | -$10.11 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $109.05 | $100.29 | $96.58 | $90.6 |
| Inventory | $7.39 | $7.09 | $8.58 | $8.78 |
| Total current assets | $406.24 | $353.93 | $426.64 | $456.75 |
| Long term investments | ||||
| Property, plant & equipment | $587.53 | $627.05 | $677.11 | $699.37 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1310.8 | $1275.45 | $1403.4 | $1362.13 |
| Current liabilities | ||||
| Accounts payable | $19.19 | $16.96 | $22.49 | $21.11 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $214.48 | $197.89 | $263.2 | $281.23 |
| Long term debt | $0.86 | $5.84 | $10.54 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $402.04 | $401.17 | $500.39 | $566.96 |
| Shareholders' equity | ||||
| Retained earnings | $687.6 | $656.66 | $669.08 | $563.02 |
| Other shareholder equity | -$6.6 | -$9.53 | $1.6 | $5.06 |
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2022 | 29 Jul 2022 | 30 Apr 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $270.84 | $271.36 | $278.98 | $283.43 |
| Cost of revenue | ||||
| Gross Profit | $97.64 | $96.42 | $108.29 | $126.01 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $93.43 | $91.72 | $93.91 | $86.9 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$1.14 | $1.36 | $5.19 | $5.04 |
| Interest expense | -$8.46 | -$1.18 | $6.16 | $11.71 |
| Net income | ||||
| Net income | -$2.43 | $3.2 | $15.32 | $15.79 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 | 31 Jan 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1074.3 | $1028.22 | $996.38 | $980.35 |
| Cost of revenue | ||||
| Gross Profit | $455.64 | $434.13 | $403.55 | $397.63 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $374.09 | $336.91 | $351.38 | $336.86 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $10.95 | $10.43 | $20.04 | $14.75 |
| Interest expense | $98.27 | $2.87 | $35.84 | $14.11 |
| Net income | ||||
| Net income | $138.59 | $41.87 | $68.21 | $58.96 |
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2022 | 29 Jul 2022 | 30 Apr 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$8.81 | -$8.16 | -$5.92 | -$65.89 |
| Financing activities | ||||
| Dividends paid | -$25.83 | -$17 | -$8.49 | -$32.03 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$35.54 | -$18.8 | -$10.45 | -$35.26 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$47.54 | -$28.18 | -$43.83 | -$38.76 |
| (in millions $) | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 | 31 Jan 2019 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$65.89 | -$63.88 | -$14.27 | -$33.66 |
| Financing activities | ||||
| Dividends paid | -$32.03 | -$31.92 | -$31.21 | -$29.83 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$35.26 | -$41.89 | -$79.75 | -$77.27 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$38.76 | $97.49 | $6.09 | -$12.5 |
News
Fundamentals
| Market cap | $1.96B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 15.42M |
| Revenue | $1.10B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $31.88M |
| Revenue Q/Q | -2.13% |
| Revenue Y/Y | 5.13% |
| P/E ratio | 61.48 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.77 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $2.07 |
|---|---|
| ROA | 2.43% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.06 |
| Quick ratio | 2.03 |